Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
GlycoMimetics
company
About
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $15.40M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2003
- Number Of Employee
- 51 - 100
- Operating Status
- Active
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$20.50M
GlycoMimetics has raised a total of
$20.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 23, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 23, 2006 | Series B | $15.40M | 1 | — | — | Detail |
| Aug 6, 2004 | Series A | $5.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
GlycoMimetics is funded by 1 investors.
Maryland Department of Business and Economic Development
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Maryland Department of Business and Economic Development
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
